{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06364748",
            "orgStudyIdInfo": {
                "id": "002-2024-Shalowitz"
            },
            "organization": {
                "fullName": "West Michigan Cancer Center",
                "class": "OTHER"
            },
            "briefTitle": "Expanding Access to Care Through Telemedical Support for Vital Sign Monitoring in High-risk Patients With Cancer",
            "officialTitle": "Expanding Access to Care Through Telemedical Support for Vital Sign Monitoring in High-risk Patients With Cancer",
            "therapeuticArea": [
                "Cardiovascular"
            ],
            "study": "expanding-access-to-care-through-telemedical-support-for-vital-sign-monitoring-in-high-risk-patients-with-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-03-11",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-03",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-09",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-03-05",
            "studyFirstSubmitQcDate": "2024-04-09",
            "studyFirstPostDateStruct": {
                "date": "2024-04-15",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-09",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-15",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "David Shalowitz",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "West Michigan Cancer Center"
            },
            "leadSponsor": {
                "name": "West Michigan Cancer Center",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Veta Health",
                    "class": "UNKNOWN"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "A randomized trial of remote blood pressure monitoring, compared to usual care, in patients receiving bevacizumab to determine whether remote blood pressure monitoring improves the collection of blood pressure data, identification and management of clinically significant hypertension, and patient satisfaction.",
            "detailedDescription": "Remote patient monitoring (RPM) technology has the potential to improve the early detection and management of clinically significant hypertension in cancer patients undergoing therapy with bevacizumab, by allowing immediate communication of abnormal measurements to the clinical care team. Additionally, RPM may decrease patients' and caregivers' burdens of ongoing cancer care through an improved user experience compared to usual care."
        },
        "conditionsModule": {
            "conditions": [
                "Hypertension"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "SUPPORTIVE_CARE",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 72,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Smart Cuff Group",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Smart blood pressure cuff",
                    "interventionNames": [
                        "Device: Cellular enabled blood pressure cuff"
                    ]
                },
                {
                    "label": "Control Group",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Standard of care",
                    "interventionNames": [
                        "Device: Standard of Care Cuff"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "Cellular enabled blood pressure cuff",
                    "description": "Smart cuff",
                    "armGroupLabels": [
                        "Smart Cuff Group"
                    ]
                },
                {
                    "type": "DEVICE",
                    "name": "Standard of Care Cuff",
                    "description": "Standard blood pressure cuff",
                    "armGroupLabels": [
                        "Control Group"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "To determine whether remote blood pressure monitoring improves adherence to recommendations for daily systolic and diastolic blood pressure monitoring compared to usual care",
                    "description": "Comparing the number of participants who complete the recommended daily blood pressure readings available for clinician assessment via review of a remote blood pressure monitoring platform versus a patient recorded blood pressure log book",
                    "timeFrame": "Through study completion, an average of 12 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Improvement of early identification of bevacizumab-induced hypertension with usual care blood pressure monitoring",
                    "description": "Frequency of clinician notifications of clinically significant elevations in systolic and/or diastolic blood pressure readings",
                    "timeFrame": "Through study completion, an average of 18 months"
                },
                {
                    "measure": "Improvement of early identification of bevacizumab-induced hypertension with remote blood pressure monitoring",
                    "description": "Frequency of clinician notifications of clinically significant elevations in systolic and/or diastolic blood pressure readings",
                    "timeFrame": "Through study completion, an average of 18 months"
                },
                {
                    "measure": "Patient satisfaction with usual care blood pressure monitoring",
                    "description": "Patient questionnaire containing seven questions, using a 5-point Likert scale, where 1 equals \"Strongly Disagree\" and 5 equals \"Strongly Agree\" for six questions. One question is measured using a 5-point Likert scale, where 1 equals \"Very Difficult\" and five equals \"Not Difficult At All\"",
                    "timeFrame": "1 week after enrollment, 6 weeks after enrollment and 12 weeks after enrollment"
                },
                {
                    "measure": "Patient satisfaction with remote blood pressure monitoring",
                    "description": "Patient questionnaire sent via mobile application by Veta Health, containing seven questions, using a 5-point Likert scale, where 1 equals \"Strongly Disagree\" and 5 equals \"Strongly Agree\" for six questions. One question is measured using a 5-point Likert scale, where 1 equals \"Very Difficult\" and five equals \"Not Difficult At All\"",
                    "timeFrame": "1 week after enrollment, 6 weeks after enrollment and 12 weeks after enrollment"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Participant is a male or female 18 years of age or older.\n2. Participant is a current patient at West Michigan Cancer Center/Bronson Cancer Center.\n3. Participant is receiving bevacizumab as part of active treatment.\n4. Participant is willing and able to provide written informed consent.\n\nExclusion Criteria:\n\n1. Participant is unable to understand English.\n2. Participant is hospitalized.\n3. Participants are unable to obtain blood pressure readings at home.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Wendi Mitchell",
                    "role": "CONTACT",
                    "phone": "269-373-7443",
                    "email": "research@wmcc.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "David Shalowitz",
                    "affiliation": "West Michigan Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "West Michigan Cancer Center",
                    "status": "RECRUITING",
                    "city": "Kalamazoo",
                    "state": "Michigan",
                    "zip": "49007",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Wendi Mitchell",
                            "role": "CONTACT",
                            "phone": "269-373-7443",
                            "email": "wmitchell@wmcc.org"
                        },
                        {
                            "name": "Kathleen Allen",
                            "role": "CONTACT",
                            "phone": "269-373-7452",
                            "email": "kallen@wmcc.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.29171,
                        "lon": -85.58723
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006973",
                    "term": "Hypertension"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10024",
                    "name": "Hypertension",
                    "asFound": "Hypertension",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}